Gout Arthritis Clinical Trial
Official title:
NLRP3 Inflammasome Activation Among Patients During Acute Gout Flares
Gout is a chronic joint disease associated with deposition of monosodium urate crystals, as a consequence of hyperuricemia. Gout is an intermittent flaring condition and acute gout flares are driven by NLRP3 inflammasome and IL1-beta production. However pathogenesis of acute gout flares remains poorly known in vivo in human. The aim of this study is to evaluate NLRP3 inflammasome activation in vivo in patients cells during acute gout flares.
Blood and synovial fluid will be obtained from remainder of patients' samples during an acute gout flares. White blood cells will be isolated and NLRP3 inflammasome activation will be assessed. Then, NLRP3 inflammasome inhibitors will be tested on cells with NLRP3 inflammasome activity. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT06277752 -
A Study to Investigate the Pharmacokinetic/Pharmacodynamic Characteristics of IBI128(A New Xanthine Oxidase Inhibitor)
|
Phase 1 | |
| Recruiting |
NCT06270225 -
A Study of SSGJ-613 in Gout Subjects Initiating Urate-Lowering Treatment.
|
Phase 2 | |
| Completed |
NCT04587544 -
The Relationship Between Cold Water Immersion and the Progression in Gout Arthritis
|
N/A | |
| Not yet recruiting |
NCT05678049 -
Evaluation and Characterisation of Microplastics and Nanoplastics in Joint Synovial Liquid
|